Rubrik crushed FQ4 earnings and provided a fairly decent outlook, providing a good cushion for its valuation. Compared to peers, its growth is higher, and its valuation is lower; it's an outperformer in this sector. While it's still tracking its subscription transition well, the stock chart may not be quite ready to start the next rally.

image for news Rubrik: The Current Cybersecurity Outperformer, But Not Immune To Sentiment

HSBC is considering outsourcing some of its fixed income trading order flow to a third-party firm, Bloomberg News reported on Monday, citing sources familiar with the matter.

image for news HSBC mulls outsourcing some fixed income trading, Bloomberg News reports

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your e.l.f. Beauty, Inc. (NYSE:ELF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/e-l-f-beauty-lawsuit-submission-form?prid=138282&wire=1 or contact Joseph E.

image for news e.l.f. Beauty, Inc. Class Action: Levi & Korsinsky Reminds e.l.f. Beauty Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - ELF

Transaction in Own Shares — Neutral

SHEL   GlobeNewsWire — March 24, 2025

Transaction in Own Shares 24 March, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 24 March 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 24/03/2025 600,000 £ 27.4300 £ 27.1600 £ 27.2781 LSE GBP 24/03/2025 100,000 £ 27.4300 £ 27.1750 £ 27.2775 Chi-X (CXE) GBP 24/03/2025 100,000 £ 27.4300 £ 27.1700 …

image for news Transaction in Own Shares

Is Visa Stock Worth Buying Now After a 24.4% Surge in 6 Months? — Positive

V   Zacks Investment Research — March 24, 2025

Higher processed transactions, increased payment volumes and a continued rise in cross-border activity are boosting V.

image for news Is Visa Stock Worth Buying Now After a 24.4% Surge in 6 Months?

Fed's Stagflation Fears Weigh, Yet Growth Factors Make BSX Stock a Buy — Negative

BSX   Zacks Investment Research — March 24, 2025

Boston Scientific, with substantial operations in China and Europe, faces significant risks due to escalating global trade tensions in 2025.

image for news Fed's Stagflation Fears Weigh, Yet Growth Factors Make BSX Stock a Buy

What Makes Horace Mann (HMN) a Strong Momentum Stock: Buy Now? — Positive

HMN   Zacks Investment Research — March 24, 2025

Does Horace Mann (HMN) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news What Makes Horace Mann (HMN) a Strong Momentum Stock: Buy Now?

What Makes Astronics Corporation (ATRO) a Strong Momentum Stock: Buy Now? — Positive

ATRO   Zacks Investment Research — March 24, 2025

Does Astronics Corporation (ATRO) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news What Makes Astronics Corporation (ATRO) a Strong Momentum Stock: Buy Now?

AerSale Corporation (ASLE) Is Up 1.82% in One Week: What You Should Know — Positive

ASLE   Zacks Investment Research — March 24, 2025

Does AerSale Corporation (ASLE) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news AerSale Corporation (ASLE) Is Up 1.82% in One Week: What You Should Know

What Makes Avista (AVA) a Strong Momentum Stock: Buy Now? — Positive

AVA   Zacks Investment Research — March 24, 2025

Does Avista (AVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news What Makes Avista (AVA) a Strong Momentum Stock: Buy Now?

All You Need to Know About W&T (WTI) Rating Upgrade to Buy — Positive

WTI   Zacks Investment Research — March 24, 2025

W&T (WTI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news All You Need to Know About W&T (WTI) Rating Upgrade to Buy

All You Need to Know About Viking (VIK) Rating Upgrade to Strong Buy — Positive

VIK   Zacks Investment Research — March 24, 2025

Viking (VIK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news All You Need to Know About Viking (VIK) Rating Upgrade to Strong Buy

All You Need to Know About Kingstone Companies (KINS) Rating Upgrade to Strong Buy — Positive

KINS   Zacks Investment Research — March 24, 2025

Kingstone Companies (KINS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news All You Need to Know About Kingstone Companies (KINS) Rating Upgrade to Strong Buy

DarioHealth (DRIO) Upgraded to Strong Buy: Here's What You Should Know — Positive

DRIO   Zacks Investment Research — March 24, 2025

DarioHealth (DRIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news DarioHealth (DRIO) Upgraded to Strong Buy: Here's What You Should Know

Banner (BANR) Upgraded to Strong Buy: What Does It Mean for the Stock? — Positive

BANR   Zacks Investment Research — March 24, 2025

Banner (BANR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Banner (BANR) Upgraded to Strong Buy: What Does It Mean for the Stock?

Compass (COMP) Upgraded to Buy: Here's What You Should Know — Positive

COMP   Zacks Investment Research — March 24, 2025

Compass (COMP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

image for news Compass (COMP) Upgraded to Buy: Here's What You Should Know

NEW YORK CITY, NY / ACCESS Newswire / March 24, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against FMC Corporation ("FMC" or the "Company") (NYSE:FMC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in FMC Corporation of Class Action Lawsuit and Upcoming Deadlines - FMC

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your enCore Energy Corp. (NASDAQ:EU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/encore-energy-corp-lawsuit-submission-form?prid=138302&wire=1 or contact Joseph E. Levi, Esq.

image for news Lost Money on enCore Energy Corp. (EU)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / If you suffered a loss on your Rocket Lab USA, Inc. (NASDAQ:RKLB) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-lab-usa-inc-lawsuit-submission-form?prid=138303&wire=1 or contact Joseph E. Levi, Esq.

image for news Rocket Lab USA, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RKLB

NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Neumora Therapeutics, Inc. ("Neumora" or the "Company") (NASDAQ:NMRA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Neumora Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NMRA